Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H19FN4S |
| Molecular Weight | 330.423 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC(F)=C3
InChI
InChIKey=JBHUBOISLBWHAR-UHFFFAOYSA-N
InChI=1S/C17H19FN4S/c1-11-9-13-16(22-7-5-21(2)6-8-22)19-15-10-12(18)3-4-14(15)20-17(13)23-11/h3-4,9-10,20H,5-8H2,1-2H3
| Molecular Formula | C17H19FN4S |
| Molecular Weight | 330.423 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Flumezapine, an antagonist of central dopamine and serotonin receptors. | 1986-10 |
|
| Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats. | 1985-10 |
|
| Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats. Characterization by the use of antagonists. | 1984-12 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:11 GMT 2025
by
admin
on
Mon Mar 31 17:56:11 GMT 2025
|
| Record UNII |
NA9GM10X6C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
61325-80-2
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
C174753
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
Flumezapine
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
DTXSID60976813
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
100000080689
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
C045983
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
NA9GM10X6C
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
135413528
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL273786
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
5123
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY | |||
|
SUB07702MIG
Created by
admin on Mon Mar 31 17:56:11 GMT 2025 , Edited by admin on Mon Mar 31 17:56:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |